Complete information for patient information, patient identifier = (b)(6).This report is being filed on an international product, list number 2k91-32 that has a similar product distributed in the us, list number 2k91-33.There was no further patient information provided by the customer.A review of complaints found no other complaints for the architect ca19-9xr assay, lot 85040m800 and no trends for the product in the field.Return testing was not completed as returns were not available.Historical performance of reagent lot 85040m800 was evaluated using world wide data from abbott link.The patient data was analyzed and compared to an established control limit.This evaluation indicated that the patient median result for lot 85040m800 is within the established control limits.Therefore, no unusual reagent lot performance was identified.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of labeling concluded that the issue is adequately addressed.Based on the investigation no product deficiency was identified for architect ca19-9xr, lot 85040m800.
|